Informações:
Falhas:
ID
14404
Descrição
Monitoring Asthma Treatment Using Exhaled Nitric Oxide; ODM derived from: https://clinicaltrials.gov/show/NCT00562991
Link
https://clinicaltrials.gov/show/NCT00562991
Palavras-chave
Versões (1)
- 13/04/2016 13/04/2016 -
Titular dos direitos
CC BY-NC 3.0
Transferido a
13 de abril de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Asthma NCT00562991
Eligibility Asthma NCT00562991
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT00562991
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
age
Item
male or female children, aged 6-14 years
boolean
C0001779 (UMLS CUI [1])
asthma
Item
a documented history of asthma for a period of at least 6 months
boolean
C0004096 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
mild to severe persistent asthma
Item
mild to severe persistent asthma according to gina guidelines
boolean
C2945599 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C3266628 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,2])
C3266628 (UMLS CUI [1,3])
allergic sensitization
Item
a documented history of allergic sensitization (positive skin prick test or specific ige
boolean
C3662483 (UMLS CUI [1])
C0430561 (UMLS CUI [2])
C0430561 (UMLS CUI [2])
subject's guardian/parent should be able to complete a symptom score on behalf of the subject
Item
subject's guardian/parent should be able to complete a symptom score on behalf of the subject.
boolean
C1321605 (UMLS CUI [1])
subject's guardian/parent should be able to send a symptom score weekly by sms
Item
subject's guardian/parent should be able to send a symptom score weekly by sms
boolean
C1321605 (UMLS CUI [1])
written informed consent
Item
both parents have to give written informed consent to participate in the study
boolean
C0021430 (UMLS CUI [1])
investigational drug
Item
received any investigational study medication in the 4 weeks prior to screening visit
boolean
C0013230 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
significant comorbidity
Item
significant comorbidity such as concurrent infection, history of prematurity, history of bronchopulmonary dysplasia, cystic fibrosis, other chronic lung diseases, and other severe chronic diseases
boolean
C0009488 (UMLS CUI [1])
asthma exacerbation
Item
acute asthma exacerbation within 4 weeks of screening visit
boolean
C0349790 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
hospitalization
Item
hospitalization within 12 weeks of screening visit
boolean
C0019993 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
systemic corticosteroids
Item
systemic corticosteroids within 12 weeks of screening visit
boolean
C4039704 (UMLS CUI [1])
oral corticosteroid dependence
Item
oral corticosteroid dependence
boolean
C0001617 (UMLS CUI [1,1])
C0442027 (UMLS CUI [1,2])
C0439857 (UMLS CUI [1,3])
C0442027 (UMLS CUI [1,2])
C0439857 (UMLS CUI [1,3])